2020-10-20

1: Dean B, Hopper S, Conn PJ, Scarr E. Changes in BQCA Allosteric Modulation of 
[(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. 
Neuropsychopharmacology. 2015 Oct 29. doi: 10.1038/npp.2015.330. [Epub ahead of 
print] PubMed PMID: 26511338.

2: Davie BJ, Valant C, White JM, Sexton PM, Capuano B, Christopoulos A, Scammells 
PJ. Synthesis and pharmacological evaluation of analogues of benzyl quinolone 
carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the 
M ₁ muscarinic acetylcholine receptor. J Med Chem. 2014 Jun 26;57(12):5405-18. 
doi: 10.1021/jm500556a. Epub 2014 Jun 5. PubMed PMID: 24856614.

3: Mistry SN, Valant C, Sexton PM, Capuano B, Christopoulos A, Scammells PJ. 
Synthesis and pharmacological profiling of analogues of benzyl quinolone 
carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor. J 
Med Chem. 2013 Jun 27;56(12):5151-72. doi: 10.1021/jm400540b. Epub 2013 Jun 17. 
PubMed PMID: 23718562.